CIRM provides funding across five key areas: Infrastructure, Education, Discovery Research, Translational Research, and Clinical Research. By supporting projects at every stage of development, from initial discovery to clinical trials, CIRM drives progress in regenerative medicine and accelerates innovative therapies to patients.
Check out our portfolio of awards below. Click here to see a list of People We’ve Funded. Click here to see a list of our Funded Institutions.
All CIRM Grants
Search Filters »
Institution |
Researcher name |
Grant Type |
Grant Title |
Award Value |
University of California, San Diego |
Jonathan Sebat |
ReMIND – Discovery Stage ReMIND |
Modeling the genetic basis of psychopathology in schizophrenia and autism |
$12,703,708 |
University of California, San Francisco |
Mercedes Paredes |
ReMIND – Discovery Stage ReMIND |
Multi-gene modulation to rescue CNS-associated microdeletion syndromes |
$5,505,959 |
University of California, Los Angeles |
Aparna Bhaduri PhD |
ReMIND – Discovery Stage ReMIND |
Defining Neurovascular Metabolism in Neurodevelopmental and Neuropsychiatric Disorders |
$10,330,000 |
University of California, San Francisco |
Tomasz Nowakowski |
ReMIND – Discovery Stage ReMIND |
CIRM Center for Neuropsychiatric Stem Cell Proteomics |
$13,781,522 |
Scripps Research Institute |
Xin Jin |
ReMIND – Discovery Stage ReMIND |
Translational epigenomics: dissecting cell type-specific function of neuropsychiatric risk genes in vivo |
$11,376,314 |
Scripps Research Institute |
Stuart A Lipton |
ReMIND – Discovery Stage ReMIND |
Multiomic Studies of Idiopathic Intellectual Disability and Autism Spectrum Disorder (ID/ASD) |
$17,365,387 |
University of California, San Francisco |
Alex Pollen |
ReMIND – Discovery Stage ReMIND |
Deep phenotyping of human brain organoid models of autism spectrum disorder to unravel disease heterogeneity and develop biomarkers and treatments |
$12,297,272 |
Coast to Coast Conferences & Events |
Calli France |
Conference – 2025 CIRM Trainee Network Conference |
2025 CIRM Trainee Networking Conference |
$413,145 |
University of Southern California |
Dr. Francesca Mariani |
Conference – 2025 CIRM Trainee Network Conference |
Manage the 2024 CIRM Annual Trainee Network Conference |
$348,626 |
EVERSANA |
Ms. Liana Rostamian |
Patient Support Program |
Patient Support Program to Improve Accessibility to Eligible CIRM-Trial Patients |
$2,485,000 |
Cedars-Sinai Medical Center |
Arun Sharma |
Shared Labs Grant – Enhancing/Expanding SRLs |
Shared Resource Laboratory for Advanced Stem Cell-Based Modeling |
$3,991,879 |
Gladstone Institutes, J. David |
Dr. Bruce R. Conklin |
Shared Labs Grant – Enhancing/Expanding SRLs |
A Center for Stem Cell Disease Modeling and Therapeutics |
$4,000,000 |
University of California, Santa Barbara |
Dr. Dennis O. Clegg Dr. |
Shared Labs Grant – Enhancing/Expanding SRLs |
Shared Resources Laboratory for Stem Cell-Based Modeling in Stem Cell Biology and Engineering |
$3,999,995 |
Salk Institute for Biological Studies |
Dr. Fred H Gage |
Shared Labs Grant – Enhancing/Expanding SRLs |
Shared Resource Laboratory for Stem Cell-Based Modeling: Resources for Exploring the Biological Underpinnings of Aging and Age-Associated Pathologies |
$3,641,064 |
University of Southern California |
Dr. Nils O. Lindstrom |
Shared Labs Grant – Enhancing/Expanding SRLs |
CIRM ASCEND Center – Advancing Stem Cell Education and Novel Discoveries |
$3,663,163 |
University of California, Los Angeles |
Dr. Kathrin Plath Dr. |
Shared Labs Grant – Enhancing/Expanding SRLs |
A modular automation approach to stem cell modeling to increase throughput, reproducibility and access |
$3,999,999 |
University of California, Irvine |
Craig M. Walsh |
Shared Labs Grant – Enhancing/Expanding SRLs |
Shared Resources Laboratories to Enhance In Vitro Stem Cell Modeling and Training |
$3,641,396 |
Humboldt State University Sponsored Programs Foundation |
Dr Amy Sprowles |
Shared Labs Grant – Establishing SRLs |
Cal Poly Humboldt Shared Resource Laboratory for Human Stem Cell-Based Modeling (SRL-hSC) |
$4,399,888 |
University of California, Merced |
Dr. Kara E McCloskey |
Shared Labs Grant – Establishing SRLs |
UCM Resources for Expanding Stem cell-derived Tissues and Organs for Regenerative Engineering (RESTORE) |
$5,396,133 |
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center |
Denise Al Alam PhD |
Shared Labs Grant – Establishing SRLs |
Stem cell-based Parternship Resource for Investigating Human Diseases and Training (SPRINT) |
$5,400,000 |
City of Hope, Beckman Research Institute |
Dr. Nadia Carlesso Ph.D., M.D. |
Shared Labs Grant – Establishing SRLs |
Stem Cell-based Disease Modeling Shared Resource Laboratory |
$5,400,000 |
University of California, Davis |
Brian Fury |
Manufacturing Network Grant |
Creating A Collaborative California Cell and Gene Therapy Manufacturing Network |
$1,543,522 |
City of Hope, Beckman Research Institute |
Dr. Taby Ahsan |
Manufacturing Network Grant |
Scalable Expansion for Stem Cell-derived Therapies |
$1,998,174 |
University of California, Los Angeles |
Dr. Dawn Ward |
Manufacturing Network Grant |
Enhancing California’s Manufacturing of Leading-Edge Cell & Gene Therapies |
$2,000,000 |
University of California, San Francisco |
Dr Brian Rudolph Shy |
Manufacturing Network Grant |
Open Manufacturing Network for Cell and Gene Therapies |
$1,999,933 |
University of Southern California |
Mohamed Abou-el-Enein |
Manufacturing Network Grant |
Advancing Cell Therapy Manufacturing Through Collaboration |
$1,999,964 |
Stanford University |
Steve Feldman |
Manufacturing Network Grant |
Laboratory for Cell and Gene Medicine: A partner in the California Cell and Gene Therapy Manufacturing Network |
$2,000,000 |
University of California, Irvine |
Dr. Aileen J Anderson |
Manufacturing Network Grant |
The UCI GMP Cell and Gene Therapy Manufacturing Facility |
$2,000,000 |
Cedars-Sinai Medical Center |
Dr. Dhruv Sareen |
Manufacturing Network Grant |
A comprehensive biomanufacturing center solving bottlenecks in cell and gene therapy manufacturing to accelerate new therapies for California patients |
$2,000,000 |
University of California, San Diego |
Dan S Kaufman |
Manufacturing Network Grant |
UCSD Advanced Cell Therapy Laboratory |
$2,000,000 |
Stanford University |
Xiaojie Qiu |
Foundation – Discovery Stage Research Projects |
Mapping and modeling endothelial cell fate decisions for pulmonary arterial hypertension |
$1,540,798 |
Gladstone Institutes, J. David |
Dr. Steve M. Finkbeiner |
Foundation – Discovery Stage Research Projects |
Lewy body dementia, 𝛼-synuclein, and cell-specific mechanisms of neurodegeneration |
$1,739,760 |
Minutia, Inc. |
Katy Digovich |
Foundation – Discovery Stage Research Projects |
Immune cloaking of human stem cell-derived insulin-producing cells for curative cell therapy without immunosuppression |
$1,192,586 |
University of California, San Francisco |
Tomasz Nowakowski |
Foundation – Discovery Stage Research Projects |
Neuroimmune interactions in the developing human brain |
$1,626,000 |
University of California, Los Angeles |
Dr. M. Carrie Miceli |
Foundation – Discovery Stage Research Projects |
Interrogating Satellite Cell and Myofiber Defects and Repair in Human DMD using Single Nuclei/Single Cell RNA Sequencing of Muscle Resident Cells |
$1,578,000 |
University of California, San Diego |
Dr Marianna Alperin |
Foundation – Discovery Stage Research Projects |
Harnessing the rejuvenating capacity of pregnancy-associated factors to restore aged stem cell function |
$1,539,520 |
Sanford Burnham Prebys Medical Discovery Institute |
Aniruddha Deshpande |
Foundation – Discovery Stage Research Projects |
Investigating the SGF29/SAGA complex in regulation of normal and cancer stem cells |
$1,547,999 |
Cedars-Sinai Medical Center |
Tyler Mark Pierson |
Foundation – Discovery Stage Research Projects |
Modeling of GATAD2B-associated neurodevelopmental disorder and NuRDopathies: Investigation of cellular & molecular anomalies altering neurodevelopment |
$1,318,441 |
University of California, Los Angeles |
Michael F Wells |
Foundation – Discovery Stage Research Projects |
Village-based identification of human risk factors for viral neuropathogenesis |
$1,577,448 |
City of Hope, Beckman Research Institute |
Qiong Annabel Wang |
Foundation – Discovery Stage Research Projects |
Utilizing Age-Specific Adipocyte Progenitor Cells for Cell Therapy in Older Patients |
$1,508,997 |
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center |
Denise Al Alam PhD |
Foundation – Discovery Stage Research Projects |
Modeling and understanding alveolar hypoplasia in Down syndrome using iPSCs-derived alveolar type II cells |
$1,524,196 |
University of California, San Francisco |
Faranak Fattahi |
Foundation – Discovery Stage Research Projects |
hPSC-derived enteric ganglioids for cell therapy in gastrointestinal motility disorders |
$1,589,307 |
University of California, Los Angeles |
Dr. William Lowry Dr. |
Foundation – Discovery Stage Research Projects |
Defining the source of dysfunction in monogenic Intellectual Disability Syndrome neurons |
$1,500,337 |
University of California, Santa Cruz |
Maximilian Haeussler |
Foundation – Discovery Stage Research Projects |
An interactive data resource for hypothesis testing in stem cell single-cell gene expression and validation of the results with brain organoids |
$1,160,126 |
University of California, Los Angeles |
Dr. Kathrin Plath Dr. |
Foundation – Discovery Stage Research Projects |
Characterization and applications of human blastoids for understanding early human embryogenesis |
$1,402,137 |
University of California, San Francisco |
Tien Peng |
Foundation – Discovery Stage Research Projects |
Ex vivo fate mapping of human lung stem cell plasticity in fibrotic disease |
$1,625,998 |
University of California, Los Angeles |
Dr. Brigitte N Gomperts |
Foundation – Discovery Stage Research Projects |
Overcoming barriers for airway stem cell gene therapy for Cystic Fibrosis |
$1,472,858 |
University of California, San Francisco |
Erik Ullian |
Foundation – Discovery Stage Research Projects |
Modeling Retinitis Pigmentosa using patient-derived human iPSC organoids |
$1,380,543 |
University of California, Irvine |
Albert La Spada Ph.D. |
Foundation – Discovery Stage Research Projects |
Role of ataxin-3 polyadenylation site selection in ALS neuron toxicity and disease pathogenesis |
$1,514,416 |
University of California, Irvine |
Dr. Brian J. Cummings |
Foundation – Discovery Stage Research Projects |
Mapping the spatial and temporal responses of hESC-derived microglia to repeat mild closed head injury to identify therapeutic targets and mechanisms |
$1,339,685 |